English

BIOPROGRESS TECHNOLOGY INTERNATIONAL INC

EDGAR

Quarterly report (10-Q) · filed 2003-06-18

37 filing records in this dataset, filed from 1996-07-24 to 2003-06-18. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

50.7 thousand USD

2003-03-31 · USD

Exact inputs and evidence

Revenue: 50738 USD Source

Operating margin

-3,080.85%

2003-03-31 · %

Exact inputs and evidence

Operating Income: -1563161 USD Source
Revenue: 50738 USD Source

Operating cash flow

125 thousand USD

2003-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 125358 USD Source

Free cash flow

124 thousand USD

2003-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 125358 USD Source
Capital Expenditure: 1066 USD Source

Cash and cash equivalents: 21.6 thousand USD 2003-03-31 Source
Exact value

21648 USD
Long-term debt including current maturities: 174 thousand USD 1995-12-31 Source
Exact value

173893 USD
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2003-06-18.

Financial data available through: 2000-06-30.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 6 of 11 periods available· newest 1996-12-31
Net income: 11 of 11 periods available· newest 2000-06-30
Operating cash flow: 10 of 11 periods available· newest 2000-06-30
Capital expenditure: 5 of 11 periods available· newest 2000-06-30
Total assets: 11 of 11 periods available· newest 2000-06-30
Total liabilities: 4 of 11 periods available· newest 1999-09-30
Current assets: 11 of 11 periods available· newest 2000-06-30
Current liabilities: 11 of 11 periods available· newest 2000-06-30
Cash and cash equivalents: 10 of 11 periods available· newest 2000-06-30
Long-term debt including current maturities: 1 of 11 periods available· newest 1995-12-31
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 1.36 million

Prior period

−USD 3.02 million

1998-07-01 – 1999-06-30
Current period

−USD 4.38 million

1999-07-01 – 2000-06-30

Exact inputs and evidence

-4376479 − -3017529 = -1358950 USD

-3017529 USD · 1998-07-01 – 1999-06-30
Inspect prior input Prior source
-4376479 USD · 1999-07-01 – 2000-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 2000-06-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Year-over-year change in Net income: -1358950 USD Concept: fundies:NetIncome Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -4376479 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500094.txt#376 Input fundies:NetIncome: -3017529 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001029.txt#317
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 3.75 million

Prior period

−USD 530,732

1998-07-01 – 1999-06-30
Current period

−USD 4.28 million

1999-07-01 – 2000-06-30

Exact inputs and evidence

-4277348 − -530732 = -3746616 USD

-530732 USD · 1998-07-01 – 1999-06-30
Inspect prior input Prior source
-4277348 USD · 1999-07-01 – 2000-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 2000-06-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Year-over-year change in Operating cash flow: -3746616 USD Concept: fundies:OperatingCashFlow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4277348 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500094.txt#398 Input fundies:OperatingCashFlow: -530732 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001029.txt#335
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+237.9%

Prior period

USD 244,381

1998-07-01 – 1999-06-30
Current period

USD 825,787

1999-07-01 – 2000-06-30

Exact inputs and evidence

825787 − 244381 = 581406 USD

244381 USD · 1998-07-01 – 1999-06-30
Inspect prior input Prior source
825787 USD · 1999-07-01 – 2000-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 2000-06-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Year-over-year change in Capital expenditure: 581406 USD Concept: fundies:CapitalExpenditure Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 825787 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500094.txt#401 Input fundies:CapitalExpenditure: 244381 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001029.txt#339
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1994-12-14 – 1995-12-13	−USD 8,969 Exact value Exact value: -8969 USD 1994-12-14 – 1995-12-13: -8969 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1995-12-13 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Net Income: -8969 USD Concept: fundies:NetIncome Period: 1994-12-14 to 1995-12-13 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ANetIncome&period=1995-12-13&surface=latest&period_type=duration&start=1994-12-14&unit=USD&dimensions= Input fundies:NetIncome: -8969 USD (1994-12-14 to 1995-12-13) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000928958-96-000010.txt#612 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1995 1995-01-01 – 1995-12-31	−USD 8,969 Exact value Exact value: -8969 USD 1995-01-01 – 1995-12-31: -8969 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1995-12-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Net Income: -8969 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8969 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-98-000056.txt#646 The citation records this snapshot. The page link may show a newer release later.	−USD 939 Exact value Exact value: -939 USD 1995-01-01 – 1995-12-31: -939 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1995-12-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Operating Cash Flow: -939 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -939 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-98-000056.txt#655 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1996 1996-01-01 – 1996-12-31	−USD 154,493 Exact value Exact value: -154493 USD 1996-01-01 – 1996-12-31: -154493 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1996-12-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Net Income: -154493 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -154493 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-98-000056.txt#646 The citation records this snapshot. The page link may show a newer release later.	−USD 144,486 Exact value Exact value: -144486 USD 1996-01-01 – 1996-12-31: -144486 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1996-12-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Operating Cash Flow: -144486 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -144486 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-98-000056.txt#655 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1997 1997-01-01 – 1997-12-31	−USD 499,011 Exact value Exact value: -499011 USD 1997-01-01 – 1997-12-31: -499011 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1997-12-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Net Income: -499011 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -499011 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-99-000435.txt#1036 The citation records this snapshot. The page link may show a newer release later.	−USD 244,382 Exact value Exact value: -244382 USD 1997-01-01 – 1997-12-31: -244382 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1997-12-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Operating Cash Flow: -244382 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -244382 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-99-000435.txt#1048 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1998-01-01 – 1998-12-31	−USD 905,286 Exact value Exact value: -905286 USD 1998-01-01 – 1998-12-31: -905286 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1998-12-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Net Income: -905286 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -905286 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-99-000435.txt#1036 The citation records this snapshot. The page link may show a newer release later.	−USD 19,367 Exact value Exact value: -19367 USD 1998-01-01 – 1998-12-31: -19367 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1998-12-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Operating Cash Flow: -19367 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19367 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-99-000435.txt#1048 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1999 1998-04-01 – 1999-03-31	−USD 3.02 million Exact value Exact value: -3017529 USD 1998-04-01 – 1999-03-31: -3017529 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-03-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Net Income: -3017529 USD Concept: fundies:NetIncome Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ANetIncome&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:NetIncome: -3017529 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-000755.txt#252 The citation records this snapshot. The page link may show a newer release later.	−USD 530,732 Exact value Exact value: -530732 USD 1998-04-01 – 1999-03-31: -530732 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-03-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Operating Cash Flow: -530732 USD Concept: fundies:OperatingCashFlow Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3AOperatingCashFlow&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -530732 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-000755.txt#267 The citation records this snapshot. The page link may show a newer release later.	USD 244,381 Exact value Exact value: 244381 USD 1998-04-01 – 1999-03-31: 244381 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-03-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Capital Expenditure: 244381 USD Concept: fundies:CapitalExpenditure Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ACapitalExpenditure&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 244381 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-000755.txt#271 The citation records this snapshot. The page link may show a newer release later.	−USD 775,113 Calculation and evidence -530732 − 244381 USD Exact free cash flow: -775113 USD 1998-04-01 – 1999-03-31: -530732 USD · Inspect Operating Cash Flow · Source 1998-04-01 – 1999-03-31: 244381 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-03-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Free cash flow: -775113 USD Concept: free-cash-flow Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -530732 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-000755.txt#267 Input fundies:CapitalExpenditure: 244381 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-000755.txt#271 The citation records this snapshot. The page link may show a newer release later.
1999 1998-07-01 – 1999-06-30	−USD 3.02 million Exact value Exact value: -3017529 USD 1998-07-01 – 1999-06-30: -3017529 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-06-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Net Income: -3017529 USD Concept: fundies:NetIncome Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ANetIncome&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:NetIncome: -3017529 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001029.txt#317 The citation records this snapshot. The page link may show a newer release later.	−USD 530,732 Exact value Exact value: -530732 USD 1998-07-01 – 1999-06-30: -530732 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-06-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Operating Cash Flow: -530732 USD Concept: fundies:OperatingCashFlow Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3AOperatingCashFlow&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -530732 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001029.txt#335 The citation records this snapshot. The page link may show a newer release later.	USD 244,381 Exact value Exact value: 244381 USD 1998-07-01 – 1999-06-30: 244381 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-06-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Capital Expenditure: 244381 USD Concept: fundies:CapitalExpenditure Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ACapitalExpenditure&period=1999-06-30&surface=latest&period_type=duration&start=1998-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 244381 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001029.txt#339 The citation records this snapshot. The page link may show a newer release later.	−USD 775,113 Calculation and evidence -530732 − 244381 USD Exact free cash flow: -775113 USD 1998-07-01 – 1999-06-30: -530732 USD · Inspect Operating Cash Flow · Source 1998-07-01 – 1999-06-30: 244381 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-06-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Free cash flow: -775113 USD Concept: free-cash-flow Period: 1998-07-01 to 1999-06-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -530732 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001029.txt#335 Input fundies:CapitalExpenditure: 244381 USD (1998-07-01 to 1999-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001029.txt#339 The citation records this snapshot. The page link may show a newer release later.
1999 1998-10-01 – 1999-09-30	−USD 3.02 million Exact value Exact value: -3017529 USD 1998-10-01 – 1999-09-30: -3017529 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-09-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Net Income: -3017529 USD Concept: fundies:NetIncome Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ANetIncome&period=1999-09-30&surface=latest&period_type=duration&start=1998-10-01&unit=USD&dimensions= Input fundies:NetIncome: -3017529 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001316.txt#311 The citation records this snapshot. The page link may show a newer release later.	−USD 530,732 Exact value Exact value: -530732 USD 1998-10-01 – 1999-09-30: -530732 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-09-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Operating Cash Flow: -530732 USD Concept: fundies:OperatingCashFlow Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3AOperatingCashFlow&period=1999-09-30&surface=latest&period_type=duration&start=1998-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -530732 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001316.txt#330 The citation records this snapshot. The page link may show a newer release later.	USD 244,381 Exact value Exact value: 244381 USD 1998-10-01 – 1999-09-30: 244381 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-09-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Capital Expenditure: 244381 USD Concept: fundies:CapitalExpenditure Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ACapitalExpenditure&period=1999-09-30&surface=latest&period_type=duration&start=1998-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 244381 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001316.txt#334 The citation records this snapshot. The page link may show a newer release later.	−USD 775,113 Calculation and evidence -530732 − 244381 USD Exact free cash flow: -775113 USD 1998-10-01 – 1999-09-30: -530732 USD · Inspect Operating Cash Flow · Source 1998-10-01 – 1999-09-30: 244381 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 1999-09-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Free cash flow: -775113 USD Concept: free-cash-flow Period: 1998-10-01 to 1999-09-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -530732 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001316.txt#330 Input fundies:CapitalExpenditure: 244381 USD (1998-10-01 to 1999-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0001050502-00-001316.txt#334 The citation records this snapshot. The page link may show a newer release later.
2000 1999-04-01 – 2000-03-31	−USD 4.38 million Exact value Exact value: -4376479 USD 1999-04-01 – 2000-03-31: -4376479 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 2000-03-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Net Income: -4376479 USD Concept: fundies:NetIncome Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ANetIncome&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:NetIncome: -4376479 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500055.txt#290 The citation records this snapshot. The page link may show a newer release later.	−USD 4.28 million Exact value Exact value: -4277348 USD 1999-04-01 – 2000-03-31: -4277348 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 2000-03-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Operating Cash Flow: -4277348 USD Concept: fundies:OperatingCashFlow Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3AOperatingCashFlow&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4277348 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500055.txt#310 The citation records this snapshot. The page link may show a newer release later.	USD 825,787 Exact value Exact value: 825787 USD 1999-04-01 – 2000-03-31: 825787 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 2000-03-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Capital Expenditure: 825787 USD Concept: fundies:CapitalExpenditure Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ACapitalExpenditure&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 825787 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500055.txt#314 The citation records this snapshot. The page link may show a newer release later.	−USD 5.1 million Calculation and evidence -4277348 − 825787 USD Exact free cash flow: -5103135 USD 1999-04-01 – 2000-03-31: -4277348 USD · Inspect Operating Cash Flow · Source 1999-04-01 – 2000-03-31: 825787 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 2000-03-31 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Free cash flow: -5103135 USD Concept: free-cash-flow Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4277348 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500055.txt#310 Input fundies:CapitalExpenditure: 825787 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500055.txt#314 The citation records this snapshot. The page link may show a newer release later.
2000 1999-07-01 – 2000-06-30	−USD 4.38 million Exact value Exact value: -4376479 USD 1999-07-01 – 2000-06-30: -4376479 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 2000-06-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Net Income: -4376479 USD Concept: fundies:NetIncome Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ANetIncome&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:NetIncome: -4376479 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500094.txt#376 The citation records this snapshot. The page link may show a newer release later.	−USD 4.28 million Exact value Exact value: -4277348 USD 1999-07-01 – 2000-06-30: -4277348 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 2000-06-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Operating Cash Flow: -4277348 USD Concept: fundies:OperatingCashFlow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3AOperatingCashFlow&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4277348 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500094.txt#398 The citation records this snapshot. The page link may show a newer release later.	USD 825,787 Exact value Exact value: 825787 USD 1999-07-01 – 2000-06-30: 825787 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 2000-06-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Capital Expenditure: 825787 USD Concept: fundies:CapitalExpenditure Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958/explain?concept=fundies%3ACapitalExpenditure&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 825787 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500094.txt#401 The citation records this snapshot. The page link may show a newer release later.	−USD 5.1 million Calculation and evidence -4277348 − 825787 USD Exact free cash flow: -5103135 USD 1999-07-01 – 2000-06-30: -4277348 USD · Inspect Operating Cash Flow · Source 1999-07-01 – 2000-06-30: 825787 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOPROGRESS TECHNOLOGY INTERNATIONAL INC · 2000-06-30 BIOPROGRESS TECHNOLOGY INTERNATIONAL INC (edgar:928958) Free cash flow: -5103135 USD Concept: free-cash-flow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T05:11:42Z Snapshot: 7645c82eeeeae545f54c3af6b528c27d3324e4589be5babc9efa8e769efde2a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/928958?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4277348 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500094.txt#398 Input fundies:CapitalExpenditure: 825787 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/928958/0000914760-01-500094.txt#401 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

37 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000928958, 928958, edgar:928958

Also known as FAMOUS SAMS GROUP INC, US FLYWHEEL SYSTEMS INC

BIOPROGRESS TECHNOLOGY INTERNATIONAL INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation